Secondary Anastomosis after Preoperative Botulinum Type A Toxin Injection in a Case with Long Gap Oesophageal Atresia

Introduction

The treatment of long gap oesophageal atresia is challenging. Primary gastric pull-up or secondary anastomosis, after awaiting the spontaneous growth of the upper and lower pouch or elongation techniques, are the most common methods.[1] [2] The gastric pull-up and colonic interposition may result in long-term functional problems and delayed primary anastomosis may be difficult or impossible due to insufficient elongation. We present a case where intramural botulinum type A toxin injection in the proximal and distal pouch resulted in an additional elongation making secondary anastomosis possible.

• References

• 1 Bagolan P, Iacobelli Bd B, De Angelis P , et al. Long gap esophageal atresia and esophageal replacement: moving toward a separation?. J Pediatr Surg 2004; 39 (7) 1084-1090
• 2 Foker JE, Kendall TC, Catton K, Khan KM. A flexible approach to achieve a true primary repair for all infants with esophageal atresia. Semin Pediatr Surg 2005; 14 (1) 8-15
• 3 Vogt EC. Congenital esophageal atresia. Am J Roentgenol 1929; 22: 463-465
• 4 Gross RE. The surgery of infancy and childhood. Philadelphia: WB Saunders; 1953
• 5 Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Treatment of achalasia with intrasphincteric injection of botulinum toxin. A pilot trial. Ann Intern Med 1994; 121 (8) 590-591
• 6 Gui D, Rossi S, Runfola M, Magalini SC. Review article: botulinum toxin in the therapy of gastrointestinal motility disorders. Aliment Pharmacol Ther 2003; 18 (1) 1-16
• 7 Dressler D, Saberi FA, Barbosa ER. Botulinum toxin: mechanisms of action. Arq Neuropsiquiatr 2005; 63 (1) 180-185
• 8 Chumpitazi BP, Fishman SJ, Nurko S. Long-term clinical outcome after botulinum toxin injection in children with nonrelaxing internal anal sphincter. Am J Gastroenterol 2009; 104 (4) 976-983
• 9 Steinwegs I, Mach-Detiefsen B, Boemers T. Botox injection for primary oesophageal anastomosis in two preterm's with oesophageal atresia type IIIA and type II. Presented at the 12th European Congress of Paediatric Surgery, Barcelona, 15–18 June 2011.
• 10 Friedenberg F, Gollamudi S, Parkman HP. The use of botulinum toxin for the treatment of gastrointestinal motility disorders. Dig Dis Sci 2004; 49 (2) 165-175
• 11 James AN, Ryan JP, Parkman HP. Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle. Am J Physiol Gastrointest Liver Physiol 2003; 285 (2) G291-G297